Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis

Cited by (893)

Items 301–400 of 893

1. Nonalcoholic Fatty Liver Disease in Children.
   Katherine F. Sweeny, Christine K Lee · 2021 · PubMed Central
2. Nonalcoholic Fatty Liver Disease—A Concise Review of Noninvasive Tests and Biomarkers
   Tamara Bassal, Maamoun Basheer, Mariana Boulos, Nimer Assy · 2022 · Metabolites
3. High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican Americans
   Gordon P. Watt, Miryoung Lee, Jen‐Jung Pan, Michael B. Fallon, Rohit Seth Loomba, Laura Beretta, Joseph B. McCormick, Susan P. Fisher‐Hoch · 2018 · Clinical Gastroenterology and Hepatology
4. Two-dimensional Shear Wave Elastography with Propagation Maps for the Assessment of Liver Fibrosis and Clinically Significant Portal Hypertension in Patients with Chronic Liver Disease: A Prospective Study
   Sun Kyung Jeon, Jeong Min Lee, Ijin Joo, Jeong Hee Yoon, Dong Ho Lee, Joon Koo Han · 2019 · Academic Radiology
5. New Perspectives in Pediatric Nonalcoholic Fatty Liver Disease: Epidemiology, Genetics, Diagnosis, and Natural History
   Jae Sung Ko · 2019 · Pediatric Gastroenterology Hepatology & Nutrition
6. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound Elastography
   Monica Lupșor‐Platon, Teodora Serban, Alexandra Iulia Silion, Alexandru Tirpe, Mira Florea · 2020 · Cancers
7. Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
   Shan Hong, Yiwei Hao, Lei Sun, Ping Li, Junru Yang, Fuyang Zhang, Lingling He, Jing Zhang, Hongshan Wei · 2024 · Annals of Hepatology
8. Liver Fibrosis Is Associated With Hemorrhagic Transformation in Patients With Acute Ischemic Stroke
   Chengxiang Yuan, Yiting Ruan, Ya‐Ying Zeng, Hao-Ran Cheng, Qianqian Cheng, Yunbin Chen, Weilei He, Guiqian Huang, Jincai He · 2020 · Frontiers in Neurology
9. Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results
   Philippe Halfon, Christelle Ansaldi, Guillaume Pénaranda, Laurent Chiche, Patrick Dukan, Chloé Stavris, Anne Plauzolles, F. Rétornaz, Marc Bourlière · 2021 · PLoS ONE
10. A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone
    Serkan Duman, Diğdem Kuru, Mesut Gümüşsoy, Saba Kiremitçi, Hale Gökcan, Bahar Ulas, Zeynep Melekoğlu Ellik, Mübin Özercan, Ramazan Erdem Er, Fatih Karakaya et al. · 2023 · European Radiology
11. Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: A population-based cohort study
    Ciardullo, Stefano, Cannistraci, Rosa, Muraca, Emanuele, Zerbini, Francesca, Perseghin, Gianluca · 2024 · Nutrition, Metabolism and Cardiovascular Diseases
12. Importance of non-invasive liver fibrosis scores for mortality and complications development in individuals with type 2 diabetes
    Nathalie Carvalho Leite, Claudia R.L. Cardoso, Gil Fernando Salles · 2021 · Journal of Diabetes and its Complications
13. Management of NAFLD patients with advanced fibrosis
    Douglas Maya‐Miles, Javier Ampuero, Rocío Gallego‐Durán, Paola D’Ingianna, Manuel Romero‐Gómez · 2021 · Liver International
14. High resolution flow (HR Flow) and Glazing Flow in cases of hepatic flow changes: Comparison to color-coded Doppler sonography (CCDS)
    E.M. Jung, Sylvia Kammerer, Moritz Brandenstein, Franz Josef Putz, Christian Stroszczynski, Friedrich Jung · 2021 · Clinical Hemorheology and Microcirculation
15. Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis
    Nikolaos Perakakis, Stefan Richard Bornstein, Andreas L. Birkenfeld, Andreas Linkermann, Münevver Demir, Stefan D. Anker, Gerasimos S Filippatos, Bertram Pitt, Peter R Rossing, Luis Miguel Ruilope et al. · 2023 · Diabetes Obesity and Metabolism
16. Mapping theme trends and recognizing research hot spots in the use of ultrasound in orthopaedics: a bibliometric analysis of global research.
    Sheng Wang, Kaiwen Wu, Zhentao Zhang, Zhuoran Xu, Jianghong Wu, Shuogui Xu · 2021 · Europe PMC (PubMed Central)
17. Diagnostic Value of Serum Chitinase‐3‐Like Protein 1 for Liver Fibrosis: A Meta‐analysis
    Xiaoting Huang, Jialing Zhuang, Yongqiang Yang, Jiaxin Jian, Wen Ai, Chunyong Liu, Wenzhi Tang, Changyu Jiang, Yongshen He, Lesheng Huang et al. · 2022 · BioMed Research International
18. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts
    Allison E. Wang, Eric P. Hsieh, Barbara J. Turner, Norah A. Terrault · 2022 · Journal of General Internal Medicine
19. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?
    Athanasia Mitsala, Christos Tsalikidis, Κonstantinos Romanidis, Michail S. Pitiakoudis · 2022 · Current Oncology
20. Metabolic-associated fatty liver disease and the risk of cardiovascular disease
    Pengwei Zhang, Xianhui Dong, Wei Zhang, Shiyin Wang, Chen Chen, Jiake Tang, Yao You, Siqi Hu, Shenghui Zhang, Chunyi Wang et al. · 2022 · Clinics and Research in Hepatology and Gastroenterology
21. Liver fibrosis prevalence and risk factors in patients with psoriasis: A systematic review and meta-analysis
    Tanat Yongpisarn, Amornrut Namasondhi, Wimolsiri Iamsumang, Ploysyne Rattanakaemakorn, Poonkiat Suchonwanit · 2022 · Frontiers in Medicine
22. New concept in fatty liver diseases
    Katsutoshi Tokushige · 2023 · Hepatology Research
23. Elevated FIB-4 Is Associated with Higher Rates of Cardiovascular Disease and Extrahepatic Cancer History in Patients with Type 2 Diabetes Mellitus
    Dimitrios S. Karagiannakis, Katerina Stefanaki, Foteini Petrea, Panagiota Zacharaki, Alexandra Giannou, Olympia Michalopoulou, Paraskevi Kazakou, Θεοδώρα Ψαλτοπούλου, Vasiliki Vasileiou, Stavroula Α. Paschou · 2024 · Biomedicines
24. The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study
    Galit Weinstein, Yochai Schonmann, Hanny Yeshua, Shira Zelber‐Sagi · 2024 · Alzheimer s & Dementia
25. One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population
    Paula Iruzubieta, Rebeca Mayo, Itziar Mincholé, Ibon Martínez‐Arranz, María Teresa Arias‐Loste, Luis Ibáñez, Javier Ampuero, Javier Abad, Rosa Martín‐Mateos, Ana Belén Fernández Laso et al. · 2024 · United European Gastroenterology Journal
26. Disparities in screening and risk stratification for Hispanic adults with metabolic dysfunction–associated steatotic liver disease
    Monica A. Tincopa, Luis Antonio Díaz, Daniel Q. Huang, Juan Pablo Arab, Marco A. Arrese, Adrian Gadano, Claudia Pinto Marques Souza de Oliveira, Richele Bettencourt, Egbert V. Madamba, Susy Kim et al. · 2024 · Hepatology
27. Prevalence of liver fibrosis in an unselected general population with high prevalence of obesity and diabetes mellitus. Time for screening?
    Diego García‐Compeán, Jesús Zacarías Villarreal‐Pérez, Manuel Enrique de la O-Cavazos, Fernando Javier Lavalle-Gonzalez, Omar David Borjas-Almaguer, Ángel Noe del Cueto-Aguilera, José Alberto González, Consuelo Treviño‐Garza, Lourdes Huerta-Pérez, Héctor Jesús Maldonado-Garza · 2020 · Annals of Hepatology
28. Noninvasive Evaluation for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Shannon Kogachi, Mazen Noureddin · 2021 · Clinical Therapeutics
29. Non-invasive imaging biomarkers to assess nonalcoholic fatty liver disease: A review
    Michael J. Trujillo, Johnson Chen, Jonathan M. Rubin, Jing Sheng Gao · 2021 · Clinical Imaging
30. Liver Fat Quantification and Steatosis Grading in Fatty Liver Disease by Magnetic Resonance Imaging: Systematic Review and Meta‐Analysis
    Layan I. Al‐Huneidi, Feng Zhao, Romy Maas, Sven J. E. Ermans, Jurgen Henk Runge, Xiangbai Chen, Jim Ji, Lejla Alić · 2025 · Journal of Gastroenterology and Hepatology
31. Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies
    George Agyapong, Farzaneh Dashti, Bubu A. Banini · 2023 · Annals of the New York Academy of Sciences
32. Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests
    Jérôme Boursier, Marine Roux, Charlotte E. Costentin, Julien Chaigneau, Céline Fournier, Aldo Trylesinski, Clémence M. Canivet, Sophie Michalak, Brigitte Le Bail, Valérie Paradis et al. · 2023 · Nature Communications
33. Associations between exposure to ambient particulate matter and advanced liver fibrosis in Chinese MAFLD patients
    Yunfei Xing, Xiangyang Gao, Qin Li, Xueying Li, Youxin Wang, Yifan Yang, Shuhan Yang, Patrick W.C. Lau, Qiang Zeng, Hui Wang · 2023 · Journal of Hazardous Materials
34. Noninvasive diagnosis of liver cirrhosis: qualitative and quantitative imaging biomarkers
    Tianying Zheng, Yali Qu, Jie Chen, Jie Yang, Hualin Yan, Hanyu Jiang, Bin Song · 2024 · Abdominal Radiology
35. Serum ferritin as a biomarker for NAFLD: ready for prime time?
    Raj A. Shah, Kris V. Kowdley · 2019 · Hepatology International
36. Development of new drugs for the treatment of nonalcoholic steatohepatitis
    Jie Ting Tang, Han Ma · 2019 · Journal of Digestive Diseases
37. Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
    Ma Ai Thanda Han · 2020 · Life
38. Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease
    Mohammad Shafi Kuchay, Narendra Singh Choudhary, Sakshi Gagneja, Anu Mathew, Tarannum Bano, Parjeet Kaur, Bajarang Bahadur, Manish Kumar Singh, Harmandeep Kaur Gill, Jasjeet Singh Wasir et al. · 2021 · Journal of Gastroenterology and Hepatology
39. Diagnosis of steatohepatitis and fibrosis in biopsy-proven nonalcoholic fatty liver diseases: including two-dimension real-time shear wave elastography and noninvasive fibrotic biomarker scores
    Jie Zhou, Feng Yan, Jinshun Xu, Qiang Lu, Xianglan Zhu, Binyang Gao, Huan Zhang, Rui‐Xu Yang, Yan Luo · 2021 · Quantitative Imaging in Medicine and Surgery
40. Incremental Value of Blood-Based Markers of Liver Fibrosis in Cardiovascular Risk Stratification
    Georgios A. Georgiopoulos, Stavros Athanasopoulos, Georgios Mavraganis, Christina Konstantaki, Maria Papaioannou, Dimitrios Delialis, Lasthenis Angelidakis, Marco Sachse, Dimitrios Papoutsis, Beyza Cavlan et al. · 2024 · The Journal of Clinical Endocrinology & Metabolism
41. Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions
    Mohamad Jamalinia, Samira Saeian, Nima Nikkhoo, Amirhossein Nazerian, Kamran Bagheri Lankarani · 2025 · Metabolism and Target Organ Damage
42. Staging Liver Fibrosis: Comparison of Native T1 Mapping, T2 Mapping, and T1ρ: An Experimental Study in Rats With Bile Duct Ligation and Carbon Tetrachloride at 11. 7 T MRI
    Yimei Lu, Qianfeng Wang, Tingting Zhang, Jinning Li, Huanhuan Liu, Defan Yao, Liang Hou, Bei-Wu Tu, Dengbin Wang · 2021 · Journal of Magnetic Resonance Imaging
43. Aspartate aminotransferase-to-platelet ratio index for predicting late recurrence of hepatocellular carcinoma after radiofrequency ablation
    Xinyuan Zhang, Yujing Xin, Yi Yang, Yi Chen, Xiaojing Cao, Yanan Wang, Qingsheng Fan, Xiang Zhou, Xiao Li · 2022 · International Journal of Hyperthermia
44. A retrospective study on the relationship between fibrosis‑4 index and all‑cause mortality in patients with acute myocardial infarction
    Maolin Cao, Tingming Li, Zhifeng Li, Fang Gong, Zijun Chen · 2022 · Experimental and Therapeutic Medicine
45. Ideal Cardiovascular Health Metrics Are Associated with Reduced Severity of Hepatic Steatosis and Liver Fibrosis Detected by Transient Elastography
    Heze Fan, Chenbo Xu, Wenyuan Li, Yuzhi Huang, Rui Hua, Ying Xiong, Yuxuan Yang, Xueying Feng, Zihao Wang, Zuyi Yuan et al. · 2022 · Nutrients
46. Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages
    Miguel David Ferrer, Clara Reynés, Margalida Monserrat-Mesquida, Maria Magdalena Quetglas‐Llabrés, Cristina Bouzas, Silvia García, David Mateos, Miguel Casares, Cristina Gómez, Lucía Ugarriza et al. · 2023 · Antioxidants
47. Noninvasive differentiation of porto-sinusoidal vascular disorder from cirrhosis: a systematic review
    Suprabhat Giri, Ankita Singh, Akash Roy, Ranjan Kumar Patel, Taraprasad Tripathy, Sumaswi Angadi · 2023 · Abdominal Radiology
48. Strain-dependent shear properties of human adipose tissue in vivo
    Alice Hatt, Robert A. Lloyd, Bart Bolsterlee, Lynne E. Bilston · 2023 · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials
49. Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation
    Si-hua Tan, Xiaoli Zhou · 2023 · Clinics
50. Implementation of Machine Learning Algorithms to Screen for Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: An In-Depth Explanatory Analysis
    Shoham Dabbah, Itamar Mishani, Yana Davidov, Ziv Ben‐Ari · 2024 · Digestion
51. Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
    Swasthika Gurjar, Ramanarayana Bhat A, Raghavendra Upadhya, Revathi Panduranga Shenoy · 2025 · Lipids in Health and Disease
52. Changes in Insulin Resistance Index and the Risk of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease without Diabetes: Kangbuk Samsung Health Study
    Dae-Jeong Koo, Mi Yeon Lee, Inha Jung, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun‐Jung Rhee, Won‐Young Lee · 2021 · Endocrinology and Metabolism
53. Association of Cholecystectomy With Liver Fibrosis and Cirrhosis Among Adults in the USA: A Population-Based Propensity Score-Matched Study
    Zhi-Qin Xie, Hongxia Li, Wenliang Tan, Lei Yang, Xiaowu Ma, Wenxin Li, Qingbin Wang, Changzhen Shang, Yajin Chen · 2021 · Frontiers in Medicine
54. Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification
    Jérôme Boursier, Christophe Cassinotto, Gilles Hunault, Sarah Shili, Jerome Lebigot, Bruno Lapuyade, Adrien Lannes, Jean‐Baptiste Hiriart, Victoire Cartier, Brigitte Le Bail et al. · 2018 · Clinical Gastroenterology and Hepatology
55. Diagnostic performance of elastography on liver fibrosis in antiviral treatment-naive chronic hepatitis B patients: a meta-analysis
    Mingkai Li, Wan Sizhe, Xiaoying Wu, Ying Linda Lin, Bin Wu · 2022 · Gastroenterology report
56. TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease
    Yusuf Nadir Yilmaz · 2023 · Hepatology forum/Hepatology forum (Online)
57. A combination model of CT-based radiomics and clinical biomarkers for staging liver fibrosis in the patients with chronic liver disease
    Maowen Tang, Yuhui Wu, Na Hu, Chong Lin, Jian He, Xing Xia, Meihua Yang, Pinggui Lei, Peng Luo · 2024 · Scientific Reports
58. Clinical Utility of Genetic Variants in PNPLA3 and TM6SF2 to Predict Liver‐Related Events in Metabolic Dysfunction‐Associated Steatotic Liver Disease
    Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima et al. · 2024 · Liver International
59. Simultaneous viscosity and elasticity measurement using laser speckle contrast imaging
    Xiao Chen, Yang Wang, Jinling Lu, Pengcheng Li · 2018 · Optics Letters
60. The diagnostic and initial approach of the patient with non-alcoholic fatty liver disease: role of the primary care provider.
    Nicolás Salva-Pastor, Norberto Carlos Chávez-Tapia, Misael Uribe, Natalia Nuño‐Lámbarri · 2019 · Gastroenterology and hepatology from bed to bench.
61. Assessment of liver fibrosis markers in people with rheumatoid arthritis on methotrexate
    Debbie A. Olsson‐White, John Kevin Olynyk, Oyekoya Taiwo Ayonrinde, Shereen Paramalingam, Helen Isobel Keen · 2020 · Internal Medicine Journal
62. Nonalcoholic fatty liver disease should be considered for treatment allocation in standard management algorithms for type 2 diabetes
    Mohammad Shafi Kuchay, Narendra Singh Choudhary, Sunil Kumar Mishra, Anoop Misra · 2020 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
63. Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass
    Sophia M. Schmitz, Andreas Kroh, Alexander Hemdorff Koch, Jonathan Frederik Brozat, Christine Karolina Stier, Ulf P. Neumann, Tom Florian Ulmer, Patrick H. Alizai · 2021 · Obesity Surgery
64. The role of elastography in non-alcoholic fatty liver disease
    Antonio Liguori, Maria Elena Ainora, Laura Riccardi, Nicoletta De Matthaeis, Fabrizio Pizzolante, Antonio Gasbarrini, Maria Assunta Zocco, Antonio Grieco, Gianludovico Rapaccini, Luca Miele · 2021 · Minerva Gastroenterology
65. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept “Compensated Advanced Chronic Liver Disease”
    Koji Fujita, Tsutomu Masaki · 2021 · Journal of Clinical Medicine
66. Fibrogenesis Marker PRO-C3 Is Higher in Advanced Liver Fibrosis and Improves in Patients Undergoing Bariatric Surgery
    Pierre Bel Lassen, Nicole Nori, Pierre Bédossa, Laurent Genser, Judith Aron‐Wisnewsky, Christine Poitou, Rambabu Surabattula, Mette Juul Nielsen, M.A. Karsdal, Diana Julie Leeming et al. · 2021 · The Journal of Clinical Endocrinology & Metabolism
67. Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease ( NAFLD )
    Danielle Brandman, Marie Boyle, Stuart McPherson, Mark L. Van Natta, Arun Jayant Sanyal, Kris V. Kowdley, Brent A. Neuschwander‐Tetri, Naga Chalasani, Manal F. Abdelmalek, Norah A. Terrault et al. · 2022 · Alimentary Pharmacology & Therapeutics
68. Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis
    Theresa Bucsics, Benjamin Grasl, Arnulf Ferlitsch, Philipp Schwabl, Mattias Mandorfer, Kerstin Zinober, Rafael Stern, David Chromy, Bernhard Scheiner, Wolfgang Sieghart et al. · 2018 · Ultrasound in Medicine & Biology
69. CHD is Associated With Higher Grades of NAFLD Predicted by Liver Stiffness
    Yan Song, Ying Dang, Ping Wang, Gang Tian, Litao Ruan · 2019 · Journal of Clinical Gastroenterology
70. Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
    David Bernstein, Alexander J. Kovalic · 2022 · Metabolism Open
71. Extending a Helping Hand: Addressing Hepatitis C in Economic Migrants and Refugees
    Jordan J. Feld · 2017 · Annals of Hepatology
72. Detecting at-risk steatotic liver disease and liver fibrosis in the community
    Leon Anton Adams, Maja Sofie Thiele, Emmanuel A. Tsochatzis · 2025 · Hepatology
73. Cocaethylene, simultaneous alcohol and cocaine use, and liver fibrosis in people living with and without HIV
    Javier A. Tamargo, Kenneth E. Sherman, Rafick‐Pierre Sékaly, Rebeka Bordi, Daniela Schlatzer, Shenghan Lai, Jag H. Khalsa, Raúl N. Mandler, Richard L. Ehman, Marianna K. Baum · 2022 · Drug and Alcohol Dependence
74. Noninvasive imaging of hepatic dysfunction: A state-of-the-art review
    Ting Duan, Hanyu Jiang, Wenwu Ling, Bin Song · 2022 · World Journal of Gastroenterology
75. Setting up of a Machine Learning Algorithm for the Identification of Severe Liver Fibrosis Profile in the Asymptomatic Adult Population
    Samir Hassoun, Chiara Bruckmann, Stefano Ciardullo, Gianluca Perseghin, Francesca Di Gaudio, Francesco Broccolo · 2022 · International Journal of Medical Informatics
76. Non-invasive assessment of metabolic dysfunction–associated fatty liver disease
    C. Vikneshwaran Chandra Kumar, Ruben Skantha, Wah‐Kheong Chan · 2022 · Therapeutic Advances in Endocrinology and Metabolism
77. Improved prediction of 10‐year risk of severe liver disease in the general population using commonly available biomarkers
    Hannes Hagström, Jacinth Yan, Mats Talbäck, Anna Andréasson, Göran Walldius, Matteo Bottai, Niklas Hammar · 2022 · Alimentary Pharmacology & Therapeutics
78. Prospective study of a case-finding algorithm to detect NAFLD with advanced fibrosis in primary care patients
    Rena K. Fox, Janet N. Chu, Max L. Goldman, Kendall B. Islam, Danielle Brandman · 2023 · Hepatology Communications
79. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD
    Nimish Thakral, Hailemichael Desalegn, Luis Antonio Díaz, Daniel Cabrera, Rohit Seth Loomba, Marco A. Arrese, Juan Pablo Arab · 2024 · Seminars in Liver Disease
80. Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD
    Stefano Ciardullo, Celeste Ronchetti, Emanuele Muraca, Alice Oltolini, Silvia Perra, Eleonora Bianconi, Francesca Zerbini, Rosa Cannistraci, G. Manzoni, Amalia Gastaldelli et al. · 2020 · Journal of Endocrinological Investigation
81. Diagnostic and interventional circulating biomarkers in nonalcoholic steatohepatitis
    Monica A. Tincopa · 2020 · Endocrinology Diabetes & Metabolism
82. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease
    Kento Imajo, Yasushi Honda, Masato Yoneda, Satoru Saito, Atsushi Nakajima · 2020 · Journal of Medical Ultrasonics
83. Biochemical assessment of metabolic associated fatty liver disease
    Armando Raúl Guerra-Ruiz, Gregori Casals, Paula Iruzubieta, Marta Lalana, Alba Leis, Rosa María López, Javier Crespo, Manuel Morales‐Ruiz · 2021 · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
84. Prospective external validation of a new non‐invasive test for the diagnosis of non‐alcoholic steatohepatitis in patients with type 2 diabetes
    Thierry Poynard, Valérie Paradis, Jimmy Mullaert, Olivier Deckmyn, Nathalie Gault, Estelle Marcault, Pauline Manchon, Nassima Si Mohammed, Béatrice Parfait, Mark R. Ibberson et al. · 2021 · Alimentary Pharmacology & Therapeutics
85. Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
    Tatsunori Miyata, Yo‐ichi Yamashita, Kota Arima, Takaaki Higashi, Hiromitsu Hayashi, Katsunori Imai, Hidetoshi Nitta, Akira Chikamoto, Toru Beppu, Hideo Baba · 2021 · Annals of Gastroenterological Surgery
86. Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people
    Jessie Torgersen, Kaku So‐Armah, Matthew S. Freiberg, Matthew Bidwell Goetz, Matthew Jay Budoff, Joseph K. Lim, Tamar Hamosh Taddei, Adeel Ajwad Butt, Maria C. Rodriguez‐Barradas, Amy C. Justice et al. · 2019 · BMC Gastroenterology
87. Serum Fibrosis Tests Guide Prognosis in Metabolic Dysfunction–Associated Fatty Liver Disease Patients Referred From Primary Care
    Zhengyi Wang, Luis Calzadilla Bertot, Gary P. Jeffrey, John Joseph, George Garas, Bastiaan de Boer, Yi Huang, Gerry C. MacQuillan, Michael Wallace, Briohny W. Smith et al. · 2021 · Clinical Gastroenterology and Hepatology
88. Prospective screening for significant liver fibrosis by fibrosis-4 in primary care patients without known liver disease
    Denis Ouzan, Anne Mosnier, Guillaume Penaranda, Isabelle Daviaud, Helene Joly, Monelle Muntlak, Jean Marie Cohen · 2021 · European Journal of Gastroenterology & Hepatology
89. Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners
    Clémence M. Canivet, Sarra Smati, Adrien Lannes, Julie Brisseau, Louise Judon, Marion Le Roch, Bertrand Cariou, William Bellanger, Bruno Guerci, Jérôme Boursier · 2021 · Clinics and Research in Hepatology and Gastroenterology
90. Nonalcoholic fatty liver disease
    Evangelia S. Makri, Stergios A. Pοlyzos · 2022 · Journal of Atherosclerosis Prevention and Treatment
91. Performance of Imaging Techniques in Non-invasive Diagnosis of Non-alcoholic Fatty Liver Disease in Children: A Systematic Review and Meta-Analysis
    Qun Yu, Yiwei Liu, Peipei Hu, Feng Gao, Guoqing Huang · 2022 · Frontiers in Pediatrics
92. The utility of non‐invasive tests to assess advanced fibrosis in Asian subjects with chronic hepatitis B and concomitant hepatic steatosis
    Kenneth Weicong Lin, Rajneesh Kumar, Feng Shen, Henry Lik‐Yuen Chan, Grace Lai‐Hung Wong, Rahul Kumar, Wan Cheng Chow, Su Lin, Vincent Wai‐Sun Wong, Jian‐Gao Fan et al. · 2023 · Liver International
93. Self-Supervised Learning for Accurate Liver View Classification in Ultrasound Images with Minimal Labeled Data
    Abder-Rahman Ali, Anthony E. Samir, Peng Guo · 2023 · IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW)
94. Association of Hematological Biomarkers of Inflammation with 10-Year Major Adverse Cardiovascular Events and All-Cause Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: The ARIC Study
    Jia-Jie Wang, Zhichao Zheng, Ying Zhang · 2024 · Journal of Inflammation Research
95. Fatty Liver Disease Along Cushing Syndrome Evolution
    Maria Marengo, Claire Briet, Mathilde Munier, Jérôme Boursier, Patrice Rodien, Valentine Suteau · 2024 · The Journal of Clinical Endocrinology & Metabolism
96. Elevated serum growth differentiation factor 15 and decorin predict the fibrotic progression of metabolic dysfunction-associated steatotic liver disease
    Jae Seung Chang, Jhii-Hyun Ahn, Moon Young Kim, Kyu‐Sang Park · 2024 · Scientific Reports
97. Influence of Probe Pressure on Ultrasound-Based Shear Wave Elastography of the Liver Using Comb-Push 2-D Technology
    Marie Byenfeldt, Anders Elvin, Per Fransson · 2018 · Ultrasound in Medicine & Biology
98. Pancreas ultrasound two-dimensional shear wave elastography in healthy children
    Lisa Qiu, Andrew T. Trout, Paula S. Bennett, Jonathan R. Dillman · 2020 · Pediatric Radiology
99. A History of the Assessment of Liver Performance
    Omar Y. S. Mousa, Patrick S. Kamath · 2021 · Clinical Liver Disease
100. Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease
     Linda L Henry, Katherine Elizabeth Eberly, Dipam Shah, Ameeta Ravi Kumar, Zobair M. Younossi · 2023 · Clinics in Liver Disease